Healthcare at the centre
Access a sophisticated healthcare environment where hospitals, clinicians, research institutions and innovation stakeholders operate within a closely connected ecosystem.
Organized by
Supported by
Program Delivery Partner
Your pathway into Singapore’s healthcare ecosystem.
A focused market-entry program connecting overseas healthcare startups with Singapore’s clinical, innovation and healthcare ecosystem.
Apply Now
Applications close
11 September 2026
co11ab Founding Members
The Market Opportunity
Start in Singapore. Build towards Asia.
Singapore brings healthcare delivery, research, innovation, investment and regional connectivity into one highly connected ecosystem — creating a strategic entry point for healthcare companies looking to build a presence in Asia.
Built for innovation
Singapore combines strong research capabilities, healthcare infrastructure and an established innovation ecosystem for companies developing new healthcare technologies.
A launch point for Asia
Build relationships and market understanding in Singapore while creating a foundation for broader commercial opportunities across Asia Pacific.
The opportunity is clear. The harder question is how to get into the right rooms.
Why co11ab
Step into Singapore healthcare through co11ab.
co11ab is a BioMedTech incubator established through a tripartite alliance between National Healthcare Group (NHG), NTU Singapore and A*STAR.
Why it matters for market entry
01
Connected across Singapore's BioMedTech ecosystem
Access clinical, research and innovation networks through co11ab’s founding members — A*STAR, NTU Singapore and NHG Health.
02
Embedded in HealthCity Novena
Be closer to a healthcare precinct where hospitals, specialist centres, medical education, research and innovation come together.
03
Built for BioMedTech translation
Work with an incubator specifically focused on helping healthcare innovations move closer to real-world development and adoption.
The Program
A focused pathway into Singapore’s healthcare ecosystem.
Prepare before arrival, engage the right stakeholders in Singapore, and continue building opportunities after the immersion.
2026 Intake
Key dates
Applications Open
28
AUG
2026
2026
Final Application Deadline
11
SEP
2026
2026
Selection Outcome
2
OCT
2026
2026
Program Journey
Prepare.
Prepare.
Immerse.
Advance.
A three-phase journey designed to move from market-entry preparation to meaningful engagement and continued follow-through.
01
October 2026 • Virtual
Prepare
Get ready for Singapore by sharpening your market-entry priorities and preparing for the stakeholders and opportunities you want to pursue.
✓
Refine your Singapore market-entry strategy and priorities
✓
Identify relevant clinical, research, regulatory and commercial stakeholders
✓
Prepare for targeted stakeholder conversations during the Singapore immersion
1-to-1 Mentorship
Work with a dedicated mentor or advisor to refine your Singapore market-entry approach and prepare for the immersion.
02
22–27 October 2026 • Singapore
Singapore Immersion
Immerse
Start with a focused understanding of Singapore, validate your market-entry assumptions with relevant stakeholders, and then widen the lens toward regional and global growth.
Singapore Market Entry
Understand. Engage. Validate.
22–23 October
22
Oct
Singapore Market Entry
Understand the Singapore Market
Build the practical knowledge needed to navigate Singapore’s healthcare market — from regulatory and commercial pathways to clinical validation, distribution and local ecosystem access.
01
Regulatory
Regulatory & HSA Pathway
Understand Singapore’s Health Sciences Authority regulatory framework, including product classification, registration pathways, licensing requirements and practical considerations for progressing toward market entry.
02
Commercialisation
Commercialisation & Go-to-Market
Explore market-entry strategy, customer and stakeholder identification, go-to-market models, pricing and value proposition, together with healthcare financing and reimbursement considerations.
03
Distribution
Distribution Partnerships & Scalability
Learn how to identify and evaluate potential partners, select appropriate channel models, structure commercial relationships and build scalable distribution pathways for Singapore and Southeast Asia.
04
Clinical
Clinical Validation & Pilot Readiness
Define appropriate evidence and validation objectives, identify relevant clinical or industry partners, design meaningful pilots and translate outcomes into evidence for adoption and commercialisation.
Singapore Ecosystem Site Visits
Clustered visits to relevant healthcare, clinical, research and innovation organisations across Singapore.
23
Oct
Singapore Market Entry
Engage & Validate
Put your market-entry thinking to the test through direct engagement with Singapore healthcare stakeholders, gaining feedback, perspectives and connections relevant to your pathway into the market.
01
Ecosystem Site Visits
Continue curated visits to relevant organisations across Singapore’s healthcare ecosystem.
02
Healthcare Stakeholder Discussions
Join small-group discussions with Singapore healthcare stakeholders and receive feedback from multiple perspectives on your solution, market fit, stakeholder priorities and potential pathways for adoption.
03
Curated 1:1 Meetings
Meet relevant healthcare, clinical, commercial and ecosystem stakeholders based on your company’s market-entry priorities.
04
Investor & Market Trends Panel
Hear perspectives on Singapore and regional healthcare investment, market dynamics and emerging opportunities.
Culminating Showcase
Demo Day Showcase
Showcase your solution and connect with invited stakeholders from Singapore’s healthcare, investment and innovation ecosystem.
24
Oct
Living in Singapore
Beyond Business: Experience Singapore
Step outside the business agenda and experience what it is like to live and build in Singapore. Over lunch, connect informally with fellow founders while gaining a feel for Singapore’s liveability, connectivity and environment for entrepreneurs considering a longer-term presence here.
Singapore to Global
Broaden the lens.
26–27 October
26
Oct
Singapore to Global
Broaden Your Perspective. Expand Your Connections.
Gain broader perspectives through expert-led learning and curated conversations — connecting your Singapore market-entry journey with insights and relationships relevant to regional and global growth.
Educational Masterclasses
Gain broader global perspectives
Learn from industry experts on key issues shaping MedTech companies globally, complementing your Singapore market-entry experience with perspectives relevant to international growth.
01
Cybersecurity
02
Global Regulatory Strategies
03
Investor Perspectives
Curated Connections
Curated 1:1 Stakeholder Meetings
Continue building relevant relationships through curated conversations with healthcare, corporate, clinical, commercial and ecosystem stakeholders aligned with your company’s priorities and next stage of growth.
27
Oct
Singapore to Global
Health & Biomedical Sessions at the Singapore Week of Innovation and Technology
Connect into Singapore’s wider innovation ecosystem and engage regional and international perspectives through health and biomedical sessions at the Singapore Week of Innovation and Technology (SWITCH) — extending the lens from entering Singapore to exploring opportunities for broader growth.
03
November 2026–May 2027 • Virtual
Advance
Build on the connections made during the immersion and turn priority conversations into practical next steps.
01
Capture Opportunities
Capture key meetings, stakeholder interest and follow-up opportunities from the Singapore immersion.
02
Define Next Steps
Receive startup-level recommendations on priority follow-up actions and potential pathways forward.
03
Maintain Momentum
Continue relevant mentor and advisor touchpoints as opportunities progress.
Is your startup ready to explore Singapore as its next market?
Built for healthcare startups ready to enter the Singapore market, engage the right stakeholders and turn market-entry interest into a practical next step.
Who Should Apply
This program may be right for ...
Growth-ready overseas BioMedTech and Healthcare companies that:
Healthcare Innovation
Have a well-developed MVP, working prototype, or validated solution
Singapore Market Interest
Singapore is a market, regional base or strategic gateway that your team is seriously considering.
Active Participation
Your team can commit a founder, senior executive, or key decision-maker to participate virtually and in the in-person immersion during 22-27 Oct in Singapore.
Growth Readiness
Can demonstrate technical, clinical, and/or commercial validation
If these statements reflect your company’s current goals, we encourage you to submit an application.
Frequently Asked Questions
Before you submit your application.
Find answers to common questions about participation, selection, programme commitment and the Singapore immersion.
Have a question that is not covered here? Contact the programme team
The programme is intended for healthcare, MedTech, BioMedTech, digital health and related startups that are actively exploring Singapore as a potential market, strategic base or gateway into Asia.
No. The accelerator is designed for companies seeking to understand and explore opportunities in Singapore. Selected participants should, however, be prepared to attend the in-person programme activities in Singapore.
Applications are reviewed through a competitive selection process. The programme team considers the company’s innovation, market readiness, relevance to Singapore and ability to participate meaningfully throughout the programme.
Selected startups are expected to participate in onboarding, virtual preparation and mentoring before attending the three-day Singapore immersion. A founder or senior team member with decision-making responsibility should remain actively involved.
Yes. The in-person immersion is a core component of the accelerator. It allows participating startups to experience the ecosystem directly and engage relevant stakeholders in Singapore.
The one-time fee provides access to the accelerator programme and its organised activities. It is payable only by companies selected to participate. The standard SGD 1,000 co11ab Associate Membership fee is waived for participating startups.
No. Participants are responsible for arranging and funding their own flights, accommodation, local transport, meals and personal expenses associated with travelling to Singapore.
No. The programme is intended to help startups build a clearer understanding of the market, test assumptions and identify potential next steps. Regulatory approvals, commercial agreements, investment and market-entry outcomes are not guaranteed.
Additional team members may be able to join selected activities, subject to programme capacity and confirmation from the organising team. At least one consistent company representative should participate throughout the journey.
Each startup will leave with its own set of insights, priorities and potential follow-up actions. Companies are responsible for deciding which opportunities to pursue and continuing relevant conversations after the structured programme concludes.
Get in Touch
Questions? Let’s start a conversation.
Have questions about the program, eligibility or Singapore market entry? Get in touch with the team and we'll be happy to help.
Contact Us